We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Thermo Fisher Scientific

Thermo Fisher Scientific Inc. serves customers who are accelerating life sciences research, solving complex analytica... read more Featured Products: More products

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Glycated Albumin Is a Promising Marker for Diabetes

By LabMedica International staff writers
Posted on 30 Nov 2015
Print article
The Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer
The Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer (Photo courtesy of Thermo Fisher Scientific)
Although glucose level is the contributing factor and diagnostic marker for type 2 diabetes, there is an imperative need to look “beyond glucose” and to seek additional biomarkers that could better predict the risk for diabetes as well its diagnosis with accurate precision.

Human serum albumin is one of the most abundant plasma proteins that readily undergoes glycation, thus glycated albumin has been suggested as an additional marker for monitoring glycemic status in people with type 2 diabetes.

Scientists at the National Chemical Laboratory (Pune, India) collected blood samples from a diabetes specialized clinic as well as healthy controls. Diagnostic parameters, including fasting blood glucose, HbA1c, oral glucose tolerance test, postprandial blood sugar, lipids, urea, creatinine, and microalbumin were measured. Equal volumes of two plasma samples with similar HbA1c (deviation of less than 0.2%) were pooled, and three such pooled plasma in each group were used for mass spectrometric technical triplicate analysis.

The team used high resolution accurate mass spectrometry (HR/AM) which has paved the way for the fragment ion library that was used for quantification of glycated peptides of albumin in the context of diabetes. Glycation is a non-enzymatic chemical reaction between glucose and proteins leading to formation of advanced glycation end products (AGEs), which have been implicated in the pathogenesis of type 2 diabetes and its complications. All samples were analyzed on hybrid quadruple Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Scientific; Waltham, MA, USA).

Muthuswamy Balasubramanyam, PhD, senior author of the study said, “While earlier studies quantified only Amadori-modified lysine (AML) modifications, our study in addition characterized the carboxymethyl-lysine (CML) and carboxyethyl-lysine (CEL) modified peptides of albumin and this is an important advancement as CML and CEL are the predominant AGEs, constituting up to 80% of total AGEs. The association of CML modified peptides of albumin with prediabetes, diabetes, and microalbuminuria is a clinically relevant and therapeutically important finding.” The study was published originally online on August 1, 2015, in the journal Molecular Cell Proteomics.

Related Links:

National Chemical Laboratory 
Thermo Scientific 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.